Deerfield Management’s Q32 Bio QTTB Stock Holding History

Deerfield Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-224,295	Closed	-$62.7M	–	106
2020 Q1	$62.7M	Sell	224,295 -67,129	-23%	-$20.6M	1.99%	10
2019 Q4	$109M	Sell	291,424 -28,596	-9%	-$8.19M	3.46%	7
2019 Q3	$104M	Hold	320,020	–	–	4.25%	6
2019 Q2	$113M	Buy	320,020 +29,629	+10%	+$11.6M	4.05%	6
2019 Q1	$145M	Hold	290,391	–	–	5.56%	2
2018 Q4	$117M	Hold	290,391	–	–	4.68%	3
2018 Q3	$119M	Hold	290,391	–	–	4.28%	2
2018 Q2	$107M	Hold	290,391	–	–	3.74%	3
2018 Q1	$97.7M	Buy	+290,391	New	+$97.6M	3.39%	3

Other funds holding QTTB

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management's QTTB Position: Q2 2020 in Review

Deerfield Management sold out of Q32 Bio (QTTB) in Q2 2020, closing a stake of 224,295 shares — an estimated $62.7M sold.

Deerfield Management first reported a position in QTTB in Q1 2018 and held it in 9 quarters. The position peaked at $145M in Q1 2019. 102 funds tracked by Wall St. Rank hold QTTB as of Q2 2020.

Deerfield Management reported no remaining Q32 Bio position as of Q2 2020 after selling out during the quarter.
Deerfield Management sold 224,295 Q32 Bio shares in Q2 2020, an estimated $62.7M.
Deerfield Management first reported a position in Q32 Bio in Q1 2018 and held it in 9 quarters.
Deerfield Management's Q32 Bio position peaked at $145M in Q1 2019.
102 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2020.

Based on Deerfield Management's 13F filing for Q2 2020, filed 14 Aug 2020.